1887

Abstract

THIS ARTICLE HAS BEEN RETRACTED

Interleukin-1β (IL-1β) is a potent pro-inflammatory cytokine involved in the pathogenesis of HCV, but the sensors and underlying mechanisms that facilitate HCV-induced IL-1β proteolytic activation and secretion remains unclear. In this study, we have identified a signalling pathway leading to IL-1β activation and secretion in response to HCV infection. Previous studies have shown the induction and secretion of IL-1β through the inflammasome complex in macrophages/monocytes. Here, we report for the first time the induction and assembly of the NALP3-inflammasome complex in human hepatoma cells infected with HCV (JFH-1). We demonstrate that activation of IL-1β in HCV-infected cells involves the proteolytic processing of pro-caspase-1 into mature caspase-1 in a multiprotein inflammasome complex. Next, we demonstrate that HCV is sensed by NALP3 protein, which recruits the adaptor protein ASC for the assembly of the inflammasome complex. Using a small interfering RNA approach, we further show that components of the inflammasome complex are involved in the activation of IL-1β in HCV-infected cells. Our study also demonstrates the role of reactive oxygen species in HCV-induced IL-1β secretion. Collectively, these observations provide an insight into the mechanism of IL-1β processing and secretion, which is likely to provide novel strategies for targeting the viral or cellular determinants to arrest the progression of liver disease associated with chronic HCV infection.

Erratum

This article contains a correction applying to the following content:
Expression of concern: Hepatitis C virus activates interleukin-1β via caspase-1-inflammasome complex
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.034033-0
2012-02-01
2020-08-05
Loading full text...

Full text loading...

/deliver/fulltext/jgv/93/2/235.html?itemId=/content/journal/jgv/10.1099/vir.0.034033-0&mimeType=html&fmt=ahah

References

  1. Allen I. C., Scull M. A., Moore C. B., Holl E. K., McElvania-TeKippe E., Taxman D. J., Guthrie E. H., Pickles R. J., Ting J. P.. 2009; The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity30:556–565 [CrossRef][PubMed]
    [Google Scholar]
  2. Bartenschlager R., Lohmann V.. 2000; Replication of hepatitis C virus. J Gen Virol81:1631–1648[PubMed]
    [Google Scholar]
  3. Blight K. J., Kolykhalov A. A., Rice C. M.. 2000; Efficient initiation of HCV RNA replication in cell culture. Science290:1972–1974 [CrossRef][PubMed]
    [Google Scholar]
  4. Blight K. J., McKeating J. A., Rice C. M.. 2002; Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol76:13001–13014 [CrossRef][PubMed]
    [Google Scholar]
  5. Bryan N. B., Dorfleutner A., Rojanasakul Y., Stehlik C.. 2009; Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain. J Immunol182:3173–3182 [CrossRef][PubMed]
    [Google Scholar]
  6. Burdette D., Olivarez M., Waris G.. 2010; Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway. J Gen Virol91:681–690 [CrossRef][PubMed]
    [Google Scholar]
  7. Chang K. M.. 2003; Immunopathogenesis of hepatitis C virus infection. Clin Liver Dis7:89–105 [CrossRef][PubMed]
    [Google Scholar]
  8. Delaloye J., Roger T., Steiner-Tardivel Q. G., Le Roy D., Knaup Reymond M., Akira S., Petrilli V., Gomez C. E., Perdiguero B..other authors 2009; Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog5:e1000480 [CrossRef][PubMed]
    [Google Scholar]
  9. de Lucas S., Bartolomé J., Amaro M. J., Carreño V.. 2003; Hepatitis C virus core protein transactivates the inducible nitric oxide synthase promoter via NF-κB activation. Antiviral Res60:117–124 [CrossRef][PubMed]
    [Google Scholar]
  10. Di Bisceglie A. M.. 1997; Hepatitis C and hepatocellular carcinoma. Hepatology26:Suppl. 134S–38S [CrossRef][PubMed]
    [Google Scholar]
  11. Dostert C., Pétrilli V., Van Bruggen R., Steele C., Mossman B. T., Tschopp J.. 2008; Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science320:674–677 [CrossRef][PubMed]
    [Google Scholar]
  12. Dumoulin F. L., Leifeld L., Honecker U., Sauerbruch T., Spengler U.. 1999; Intrahepatic expression of interleukin-1β and tumor necrosis factor-α in chronic hepatitis C. J Infect Dis180:1704–1708 [CrossRef][PubMed]
    [Google Scholar]
  13. Ekert P. G., Silke J., Vaux D. L.. 1999; Caspase inhibitors. Cell Death Differ6:1081–1086 [CrossRef][PubMed]
    [Google Scholar]
  14. Gonda T. A., Tu S., Wang T. C.. 2009; Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle8:2005–2013 [CrossRef][PubMed]
    [Google Scholar]
  15. Gong G., Waris G., Tanveer R., Siddiqui A.. 2001; Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB. Proc Natl Acad Sci U S A98:9599–9604 [CrossRef][PubMed]
    [Google Scholar]
  16. Guillot L., Le Goffic R., Bloch S., Escriou N., Akira S., Chignard M., Si-Tahar M.. 2005; Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem280:5571–5580 [CrossRef][PubMed]
    [Google Scholar]
  17. Gupta S., Radha V., Furukawa Y., Swarup G.. 2001; Direct transcriptional activation of human caspase-1 by tumor suppressor p53. J Biol Chem276:10585–10588 [CrossRef][PubMed]
    [Google Scholar]
  18. Hornung V., Bauernfeind F., Halle A., Samstad E. O., Kono H., Rock K. L., Fitzgerald K. A., Latz E.. 2008; Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol9:847–856 [CrossRef][PubMed]
    [Google Scholar]
  19. Ichinohe T., Lee H. K., Ogura Y., Flavell R., Iwasaki A.. 2009; Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med206:79–87 [CrossRef][PubMed]
    [Google Scholar]
  20. Ichinohe T., Pang I. K., Iwasaki A.. 2010; Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol11:404–410 [CrossRef][PubMed]
    [Google Scholar]
  21. Kanneganti T. D.. 2010; Central roles of NLRs and inflammasomes in viral infection. Nat Rev Immunol10:688–698 [CrossRef][PubMed]
    [Google Scholar]
  22. Kanneganti T. D., Body-Malapel M., Amer A., Park J. H., Whitfield J., Franchi L., Taraporewala Z. F., Miller D., Patton J. T..other authors 2006; Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem281:36560–36568 [CrossRef][PubMed]
    [Google Scholar]
  23. Koziel M. J.. 1999; Cytokines in viral hepatitis. Semin Liver Dis19:157–169 [CrossRef][PubMed]
    [Google Scholar]
  24. Kummer J. A., Broekhuizen R., Everett H., Agostini L., Kuijk L., Martinon F., van Bruggen R., Tschopp J.. 2007; Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem55:443–452 [CrossRef][PubMed]
    [Google Scholar]
  25. Lapiński T. W.. 2001; The levels of IL-1β, IL-4 and IL-6 in the serum and the liver tissue of chronic HCV-infected patients. Arch Immunol Ther Exp (Warsz)49:311–316[PubMed]
    [Google Scholar]
  26. Li K., Chen Z., Kato N., Gale M. Jr, Lemon S. M.. 2005; Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem280:16739–16747 [CrossRef][PubMed]
    [Google Scholar]
  27. Lindenbach B. D., Evans M. J., Syder A. J., Wölk B., Tellinghuisen T. L., Liu C. C., Maruyama T., Hynes R. O., Burton D. R..other authors 2005; Complete replication of hepatitis C virus in cell culture. Science309:623–626 [CrossRef][PubMed]
    [Google Scholar]
  28. Lu L., Wei L., Peng G., Mu Y., Wu K., Kang L., Yan X., Zhu Y., Wu J.. 2008; NS3 protein of hepatitis C virus regulates cyclooxygenase-2 expression through multiple signaling pathways. Virology371:61–70 [CrossRef][PubMed]
    [Google Scholar]
  29. Mackey D., Holt B. F. III, Wiig A., Dangl J. L.. 2002; RIN4 interacts with Pseudomonas syringae type III effector molecules and is required for RPM1-mediated resistance in Arabidopsis. Cell108:743–754 [CrossRef][PubMed]
    [Google Scholar]
  30. Martinon F., Tschopp J.. 2004; Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell117:561–574 [CrossRef][PubMed]
    [Google Scholar]
  31. Martinon F., Mayor A., Tschopp J.. 2009; The inflammasomes: guardians of the body. Annu Rev Immunol27:229–265 [CrossRef][PubMed]
    [Google Scholar]
  32. Masumoto J., Taniguchi S., Nakayama J., Shiohara M., Hidaka E., Katsuyama T., Murase S., Sagara J.. 2001; Expression of apoptosis-associated speck-like protein containing a caspase recruitment domain, a pyrin N-terminal homology domain-containing protein, in normal human tissues. J Histochem Cytochem49:1269–1275 [CrossRef][PubMed]
    [Google Scholar]
  33. Moschen A. R., Fritz T., Clouston A. D., Rebhan I., Bauhofer O., Barrie H. D., Powell E. E., Kim S. H., Dinarello C. A..other authors 2011; IL-32: a new proinflammatory cytokine involved in HCV-related liver inflammation and fibrosis. Hepatology53:1819–1829 [CrossRef][PubMed]
    [Google Scholar]
  34. Muruve D. A., Pétrilli V., Zaiss A. K., White L. R., Clark S. A., Ross P. J., Parks R. J., Tschopp J.. 2008; The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature452:103–107 [CrossRef][PubMed]
    [Google Scholar]
  35. Nelson D. R., Lim H. L., Marousis C. G., Fang J. W., Davis G. L., Shen L., Urdea M. S., Kolberg J. A., Lau J. Y.. 1997; Activation of tumor necrosis factor-α system in chronic hepatitis C virus infection. Dig Dis Sci42:2487–2494 [CrossRef][PubMed]
    [Google Scholar]
  36. Parkin D. M., Pisani P., Ferlay J.. 1999; Global cancer statistics. CA Cancer J Clin49:33–64, 1 [CrossRef][PubMed]
    [Google Scholar]
  37. Pavlović D., Neville D. C., Argaud O., Blumberg B., Dwek R. A., Fischer W. B., Zitzmann N.. 2003; The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proc Natl Acad Sci U S A100:6104–6108 [CrossRef][PubMed]
    [Google Scholar]
  38. Perwez Hussain S. P., Harris C. C.. 2007; Inflammation and cancer: an ancient link with novel potentials. Int J Cancer121:2373–2380 [CrossRef][PubMed]
    [Google Scholar]
  39. Poeck H., Bscheider M., Gross O., Finger K., Roth S., Rebsamen M., Hannesschläger N., Schlee M., Rothenfusser S..other authors 2010; Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol11:63–69 [CrossRef][PubMed]
    [Google Scholar]
  40. Rajan J. V., Rodriguez D., Miao E. A., Aderem A.. 2011; The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection. J Virol85:4167–4172 [CrossRef][PubMed]
    [Google Scholar]
  41. Sumpter R. Jr, Loo Y. M., Foy E., Li K., Yoneyama M., Fujita T., Lemon S. M., Gale M. Jr. 2005; Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol79:2689–2699 [CrossRef][PubMed]
    [Google Scholar]
  42. Thomas P. G., Dash P., Aldridge J. R. Jr, Ellebedy A. H., Reynolds C., Funk A. J., Martin W. J., Lamkanfi M., Webby R. J..other authors 2009; The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity30:566–575 [CrossRef][PubMed]
    [Google Scholar]
  43. Tschopp J., Martinon F., Burns K.. 2003; NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol4:95–104 [CrossRef][PubMed]
    [Google Scholar]
  44. Vidal-Vanaclocha F., Fantuzzi G., Mendoza L., Fuentes A. M., Anasagasti M. J., Martín J., Carrascal T., Walsh P., Reznikov L. L..other authors 2000; IL-18 regulates IL-1β-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc Natl Acad Sci U S A97:734–739 [CrossRef][PubMed]
    [Google Scholar]
  45. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Kräusslich H. G..other authors 2005; Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med11:791–796 [CrossRef][PubMed]
    [Google Scholar]
  46. Waris G., Siddiqui A.. 2005; Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication. J Virol79:9725–9734 [CrossRef][PubMed]
    [Google Scholar]
  47. Waris G., Livolsi A., Imbert V., Peyron J. F., Siddiqui A.. 2003; Hepatitis C virus NS5A and subgenomic replicon activate NF-κB via tyrosine phosphorylation of IκBα and its degradation by calpain protease. J Biol Chem278:40778–40787 [CrossRef][PubMed]
    [Google Scholar]
  48. Zhang Y. L., Guo Y. J., Bin Li, Sun S. H.. 2009; Hepatitis C virus single-stranded RNA induces innate immunity via Toll-like receptor 7. J Hepatol51:29–38 [CrossRef][PubMed]
    [Google Scholar]
  49. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D. R., Wieland S. F., Uprichard S. L., Wakita T., Chisari F. V.. 2005; Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A102:9294–9299 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.034033-0
Loading
/content/journal/jgv/10.1099/vir.0.034033-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error